sermorelin/ipamorelin/cjc-1295 Tesamorelin Ipamorelin Research Peptide Blend CJC-1295 / Ipamorelin Peptide Injections

The reduction in circulating estrogen can affect the activation of estrogen receptors, potentially leading to low-estrogen diseases such as metabolic syndrome, cardiovascular diseases, and obesity

Your consultation with Celeste Cisneros, FNP-BC is included no separate consultation fee

No evidence of significant endocrine disruption, hepatic, or cardiovascular adverse effects has been observed in available data when used within researched dose ranges

Steullet P, Cabungcal JH, Monin A, Dwi D, ODonnell P, et al

Contact us today to schedule a consultation or book online and begin your journey toward optimal health and rejuvenation at Sculpt MD MedSpa

Other areas for heightened scrutiny involve payment processor transaction flags for high risk medical or wellness services such as peptide therapy